Atlas Trials

Effect of Reslizumab in Chronic Rhinosinusitis

Clinical trial NCT02799446 · UNKNOWN

Trial details

NCT number
NCT02799446
Sponsor
Joshua S. Jacobs
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Sinusitis
Start date
2016-06-01
Primary completion
2019-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.